In Brief This Week: Sequenom; Promega; Danaher; Agilent; Horizon Discovery; Silicon Biosystems; Warnex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom this week said that the American Journal of Obstetrics and Gynecology has accepted for publication a manuscript that details the results of the firm's "locked-assay" study on its Trisomy 21 test. It did not provide a planned date for the article.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers trace the deaths of a pair of newborn siblings to a mutation in their LIPT1 genes through whole-exome sequencing, Stat News reports.

In PNAS this week: system to track intron gains and losses, role of RUNX during mitosis, and more.

French officials release a report and move to strength safety measures for clinical trials, ScienceInsider reports.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.